🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Blue Journal thanks Fabien Robert, PharmD, MSc, for his contribution to the September 1 issue Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome atsjournals.org/doi/full/10.11…

🔴 J1 [JRF-HTP] : session 2 - Montani David intervient sur la réévaluation de la définition, la classification et le diagnostic de l’HTP par rapport aux guidelines ERS European Society of Cardiology Journals 2022 : déf. conservée, classe 3 modifiée avec des maladies. 🗞 erj.ersjournals.com/content/erj/ea…

Élise Noël-Savina CHU de Toulouse - compte inactif décrit les impacts des ces réévaluations pour le #diagnostic, les #cliniciens et aussi qui sont ces #patients.

#J2R : 200 participants , un superbe comité d'organisation et un joli programme sur 2 jours #Recherche #Respiratoire #Pneumologie

🔴 J2 [JRF-HTP] : session 5 - Marion Delcroix UZ Leuven présente les conclusions du #WSPH 2024 pour le traitement de l'#HTP thrombo-embolique chronique : #endartériectomie / l'#angioplastie pulmonaire et thérapie médicale ciblée HTP. 🗞 doi.org/10.1183/139930… #CTEPH #PEA #BEA

Le congrès des J2R de la SPLF. Un énorme succès à Paris dans un lieu magnifique et de la recherche de haute volée. Bravo à tous les laboratoires de recherche en pneumologie 🫁👏 👉 splf.fr/journees-de-re…

#JRF-HTP Olivier Sitbon Montani David Athénaïs Boucly Jean-Luc Vachiery 🫀 @madelcroix Vincent Cottin FSMR - RespiFIL 🫁 Pulmotension Hôpital Bicêtre AP-HP Université Paris-Saclay

The "DELPHI-2 Study" journey continue with our latest publication in Chest: "Role of Exercise Hemodynamics in the Prediction of #PAH in BMPR2 Mutation Carriers" Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 HTaPFrance Christian Gerges Harm Jan Bogaard journal.chestnet.org/article/S0012-…

Professor Humbert sharing updates from the 7th WSPH DeBakey CV Education - World Class CV Training Houston Methodist Cardiovascular Fellowships Houston Methodist PCCM Fellowship PHAEUROPE Team PHenomenal Hope The Pulmonary Hypertension Association ATS PC Assembly CHEST Pulmonary Vascular and Cardiovascular One of the most important slides!!

Amazing learning experience, discussions on PH, career mentoring, academic growth, food and fun over the last couple of days! PHAEUROPE ATS PC Assembly The Pulmonary Hypertension Association Houston Methodist Cardiovascular Fellowships Houston Methodist MD

Happy to share this recent review "Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH" published in Blood Reviews Pulmotension Laurent Bertoletti InsermU999 HTaPFrance Société de Pneumologie de Langue Française (SPLF) sciencedirect.com/science/articl…

Welcome to Grégoire Ruffenach to the Research Unit InsermU999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies". Just arrived, and already full of projects and opportunities. Happy to have you on the team. Pulmotension HTaPFrance Société de Pneumologie de Langue Française (SPLF)

Happy to share our recent collaboration published in Rheumatology : "Anti-fibroblast and anti-endothelial cell autoantibodies in SLE- and MCTD-PAH" Benjamin Thoreau Pulmotension InsermU999 Société de Pneumologie de Langue Française (SPLF) academic.oup.com/rheumatology/a…

Deeply concerning to receive #PAH study proposals from Akros Pharma, a pharmaceutical company emerging from Japan Tobacco Inc. The tobacco industry, responsible for 8 million deaths annually, has no place in medical research funding. Société de Pneumologie de Langue Française (SPLF) ERS Pulmotension

Happy to share our latest publication from the fruitful collaboration between InsermU999 & UMR-S 1180 Signaling & Cardiovasc Pathophysiol! "Ca2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction" Circulation Heart Failure Pulmotension Société de Pneumologie de Langue Française (SPLF) HTaPFrance ahajournals.org/doi/10.1161/CI…

Happy to share our latest collaborative work: "Approach to Lung Transplantation in #PAH: A Delphi Consensus" just published online in Pulmonary Circulation Savale Laurent Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 HTaPFrance onlinelibrary.wiley.com/doi/10.1002/pu…

Thanks to the journal Chest #JournalCHEST for highlighting our article on the association between trastuzumab emtansine and pulmonary arterial hypertension #PAH journal.chestnet.org/article/S0012-… Société de Pneumologie de Langue Française (SPLF) HTaPFrance InsermU999 Pulmotension

Proud to share our new publication in Respiratory Medicine and Research 'PAH-approved drugs in PH associated with COPD: a systematic literature review.' Grateful to my co-authors ! Société de Pneumologie de Langue Française (SPLF) Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 sciencedirect.com/science/articl…

Phenotyping PH in COPD is a major challenge in respiratory medicine. Grateful for the great collaboration with the Strasbourg team. Our study is now out in ERJ Open Research Pulmotension InsermU999 Société de Pneumologie de Langue Française (SPLF) HTaPFrance publications.ersnet.org/content/erjor/…

A key contribution on a major topic "Initial therapy in patients with #PAH and cardiovascular comorbidities" just published in ERS publications Thanks to Athénaïs Boucly Savale Laurent and the Pulmotension network Société de Pneumologie de Langue Française (SPLF) publications.ersnet.org/content/erj/65…